70125-82-5Relevant academic research and scientific papers
Large neutral amino acid transporter enables brain drug delivery via prodrugs
Gynther, Mikko,Laine, Krista,Ropponen, Jarmo,Lepp?nen, Jukka,Mannila, Anne,Nevalainen, Tapio,Savolainen, Jouko,J?rvinen, Tomi,Rautio, Jarkko
, p. 932 - 936 (2008/09/19)
The blood-brain barrier efficiently controls the entry of drug molecules into the brain. We describe a feasible means to achieve carrier-mediated drug transport into the rat brain via the specific, large neutral amino acid transporter (LAT1) by conjugatin
In vitro evaluation of acyloxyalkyl esters as dermal prodrugs of ketoprofen and naproxen
Rautio, Jarkko
, p. 1622 - 1628 (2007/10/03)
A series of acyloxyalkyl esters of ketoprofen and naproxen were synthesized and investigated as topical prodrugs with the aim of improving the dermal delivery of the drugs. In addition, some hydroxyalkyl esters of ketoprofen and naproxen were synthesized as possible intermediates of acyloxyalkyl prodrugs. All of the prodrugs were more lipophilic than their parent molecules, as evaluated by drug partitioning between 1-octanol and phosphate buffer at pH 7.4 (log P(app)). However, their solubilities in aqueous solutions decreased markedly compared with the parent molecules. The prodrugs were stable toward chemical hydrolysis in aqueous solutions (pH 7.4), but were hydrolyzed to the parent drug both in 80% human serum and in human skin homogenate, with half-lives ranging from 4 to 137 min and from 13 to 403 min, respectively. The abilities of the selected naproxen acyloxyalkyl prodrugs to deliver naproxen through excised human skin were evaluated. Generally, the prodrugs showed similar dermal delivery as the patent drug through cadaver skin. In the present series of lipophilic prodrugs of naproxen, the prodrug with the highest aqueous solubility was the most effective prodrug to deliver naproxen through the skin.
